V A Petrishchenko
Overview
Explore the profile of V A Petrishchenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhukov V, Shishkina L, Safatov A, Sergeev A, Piankov O, Petrishchenko V, et al.
Vestn Ross Akad Med Nauk
. 2010 Jul;
(5):24-9.
PMID: 20608042
The paper presents results of testing a modified algorithm for predicting virus ID50 values in a host of interest by extrapolation from a model host taking into account immune neutralizing...
2.
Zhukov V, Shishkina L, Sergeev A, Pliasunov I, Piankov O, Petrishchenko V, et al.
Vestn Ross Akad Med Nauk
. 2009 Dec;
(11):46-9.
PMID: 20017408
Secretory factors were isolated by lung wash followed by centrifugation to remove cells, dialysis of supernatant to remove NaCl salt, lyophilization of the lavage fluid and resuspention of the lyophilization...
3.
Agafonov A, Skarnovich M, Petrishchenko V, Shishkina L, Sergeev A, Svistov V, et al.
Antibiot Khimioter
. 2009 Jan;
50(12):9-11.
PMID: 19140480
In vitro antiviral effect of myramistin on influenza virus (MDCK cell culture) was studied. The drug showed significant dose-dependent antiviral activity against the virus. When used prophylactically (1 hour before...
4.
Zhukov V, Shishkina L, Sergeev A, Malkova E, Riabchikova E, Petrishchenko V, et al.
Vestn Ross Akad Med Nauk
. 2008 Mar;
(2):12-6.
PMID: 18368764
The levels of susceptibility to influenza virus A/Aichi/2/68 H3N2 and the virus yield were determined using primary cells of the trachea and lungs of CD-1 mice and Wistar rats, and...
5.
Zhukov V, Shishkina L, Sergeev A, Fankin I, Smetannikova M, Piankov O, et al.
Vestn Ross Akad Med Nauk
. 2007 Jul;
(5):32-7.
PMID: 17601039
To predict a potential value of a viral ID50 for a macro-organism of interest (e.g. humans), it is necessary to determine in vitro two parameters of the interaction of the...
6.
Skarnovich M, Radaeva I, Vdovichenko G, Nechaeva E, Sergeev A, Petrishchenko V, et al.
Vopr Virusol
. 2007 May;
52(2):37-40.
PMID: 17500238
The seeding and working banks of a 4647-cell culture have been created. The 4647-cell culture in these banks has a high proliferative activity, as well as the morphology, typical of...
7.
Smetannikova M, Shishkina L, Zhukov V, Fankin I, Sergeev A, Skarnovich M, et al.
Vestn Ross Akad Med Nauk
. 2007 Mar;
(1):3-8.
PMID: 17338373
The results of the study showed that subcutaneous kenalog (Kn) lowered the resistance of mice to influenza virus (InV), as was seen by a decrease in 50% lethal dose and...
8.
Vdovichenko G, Petrishchenko V, Sergeev A, Kim I, Fatiukhina O, Shishkina L, et al.
Vopr Virusol
. 2007 Jan;
51(6):39-42.
PMID: 17214082
The anticancer drug Cancerolysin has been developed, by using the mutant Adel2 variant of human adenovirus serotype 5 designed at the State Research Center of Virology and Biotechnology. Cancerolysin possesses...
9.
Smetannikova M, Shishkina L, Sergeev A, Fankin I, Bulychev L, Kolesnikova L, et al.
Vestn Ross Akad Med Nauk
. 2006 Jul;
(6):22-7.
PMID: 16869256
The study demonstrates the effects of kenalog (Kn), a synthetic glucocorticoid hormone, on the course of virus A/Aichi/2/68 influenza in white mice. In doses of 5 and 10 mg/kg, Kn...
10.
Pliasunov I, Sergeev A, Sergeev A, Petrishchenko V, Shishkina L, Generalov V, et al.
Vopr Virusol
. 2006 Jun;
51(2):31-5.
PMID: 16756176
Clinical trials of oral live recombinant embryonic variola and hepatitis B bivaccine as tablets (Revax-BT) were performed. When volunteers were prevaccinated with oral variola vaccine first in a small dose...